Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Shuttle Pharmaceuticals Delays Quarterly SEC Filing - The Globe and Mail

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals (RYTM) grants CMO 50K options expiring 2036 - Stock Titan

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Rocket Pharmaceuticals CEO Gaurav Shah sells $9,591 in company stock - Investing.com

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

6,857 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Commerzbank Aktiengesellschaft FI - MarketBeat

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals (NASDAQ:AMLX) Hits New 12-Month High Following Analyst Upgrade - MarketBeat

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Mirum Pharma (NASDAQ: MIRM) officer lines up $4M share sale - Stock Titan

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - TMX Newsfile

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Rocket Pharma (NASDAQ: RCKT) sale tied to 2026 vesting, tax bill - Stock Titan

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

BTIG Research Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Rhythm (RYTM) CMO reports no company stock holdings - Stock Titan

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock - marketscreener.com

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Chardan Capital to Neutral - MarketBeat

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP - PR Newswire

news.google.com · 19 Aug 2026

Google News – Pharmaceuticals External News

Eyepoint Pharmaceuticals' (EYPT) Sector Perform Rating Reiterated at Royal Bank Of Canada - MarketBeat

news.google.com · 19 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Trump nominates policy aide Overton to lead FDA

FDA seeks feedback on generative AI regulations

GE HealthCare names new CFO

Shuttle Pharmaceuticals Delays Quarterly SEC Filing - The Globe and Mail

Rhythm Pharmaceuticals (RYTM) grants CMO 50K options expiring 2036 - Stock Titan

Rocket Pharmaceuticals CEO Gaurav Shah sells $9,591 in company stock - Investing.com

6,857 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Commerzbank Aktiengesellschaft FI - MarketBeat

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Amylyx Pharmaceuticals (NASDAQ:AMLX) Hits New 12-Month High Following Analyst Upgrade - MarketBeat

Mirum Pharma (NASDAQ: MIRM) officer lines up $4M share sale - Stock Titan

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - TMX Newsfile

Rocket Pharma (NASDAQ: RCKT) sale tied to 2026 vesting, tax bill - Stock Titan

BTIG Research Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP) - MarketBeat

Rhythm (RYTM) CMO reports no company stock holdings - Stock Titan

Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock - marketscreener.com

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by Chardan Capital to Neutral - MarketBeat

Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman Sobol Shapiro LLP - PR Newswire

Eyepoint Pharmaceuticals' (EYPT) Sector Perform Rating Reiterated at Royal Bank Of Canada - MarketBeat